DESTIN, Fla. — Incomplete understanding of axial spondyloarthritis disease process poses challenges for treatment decision making, according to a presenter at the 2023 Congress of Clinical Rheumatology-East.“Current therapies are not rooted in a thorough understanding of disease pathogenesis,” Joerg Ermann, MD, assistant professor of medicine in the division of rheumatology,